MX2020004580A - Azabiciclo y derivados de diazepina para tratar trastornos oculares. - Google Patents
Azabiciclo y derivados de diazepina para tratar trastornos oculares.Info
- Publication number
- MX2020004580A MX2020004580A MX2020004580A MX2020004580A MX2020004580A MX 2020004580 A MX2020004580 A MX 2020004580A MX 2020004580 A MX2020004580 A MX 2020004580A MX 2020004580 A MX2020004580 A MX 2020004580A MX 2020004580 A MX2020004580 A MX 2020004580A
- Authority
- MX
- Mexico
- Prior art keywords
- azabicyclo
- treating ocular
- diazepine derivatives
- ocular disorders
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente divulgación provee en un aspecto, derivados de azabiciclo y diazepina útiles como moduladores de receptores muscarínicos. En otro aspecto, la presente invención proporciona composiciones farmacéuticas para tratar enfermedades oculares, las composiciones comprenden al menos un modulador del receptor muscarínico.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762581073P | 2017-11-03 | 2017-11-03 | |
US201862749610P | 2018-10-23 | 2018-10-23 | |
PCT/IB2018/058631 WO2019087146A1 (en) | 2017-11-03 | 2018-11-02 | Azabicyclo and diazepine derivatives for treating ocular disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020004580A true MX2020004580A (es) | 2020-12-03 |
Family
ID=64267873
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020004580A MX2020004580A (es) | 2017-11-03 | 2018-11-02 | Azabiciclo y derivados de diazepina para tratar trastornos oculares. |
MX2022011310A MX2022011310A (es) | 2017-11-03 | 2020-07-13 | Azabiciclo y derivados de diazepina para tratar trastornos oculares. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022011310A MX2022011310A (es) | 2017-11-03 | 2020-07-13 | Azabiciclo y derivados de diazepina para tratar trastornos oculares. |
Country Status (12)
Country | Link |
---|---|
US (3) | US11306090B2 (es) |
EP (1) | EP3704117A1 (es) |
JP (3) | JP7065180B2 (es) |
KR (1) | KR20200083976A (es) |
CN (1) | CN111247147A (es) |
AU (3) | AU2018362010B2 (es) |
BR (1) | BR112020007744A2 (es) |
CA (2) | CA3076457C (es) |
MX (2) | MX2020004580A (es) |
SG (1) | SG11202002692XA (es) |
TW (1) | TWI826399B (es) |
WO (2) | WO2019087146A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022523332A (ja) * | 2019-02-01 | 2022-04-22 | アエリエ ファーマシューティカルズ インコーポレイテッド | 近視を治療するための化合物、組成物及び方法 |
US20240099970A1 (en) * | 2022-09-11 | 2024-03-28 | Alcon Inc. | Aqueous pharmaceutical compositions comprising benzyl atropine and uses thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1165037B (de) | 1961-11-21 | 1964-03-12 | Dr. Schwarz Arzneimittelfabrik G.m.b.H., Monheim (RhId.) | Verfahren zur Herstellung von Estern quaternärer Atropiniumsalze. |
GB994493A (en) | 1963-02-06 | 1965-06-10 | Lepetit Spa | Tropine derivative |
DE1670177A1 (de) | 1966-12-28 | 1970-11-12 | Boehringer Sohn Ingelheim | Verfahren zur Herstellung von neuen N-substituierten Noratropiniumsalzen |
US5223528A (en) * | 1986-03-17 | 1993-06-29 | University Of Florida | Anticholinergic compounds, composititons and methods of treatment |
NZ529615A (en) | 2001-05-25 | 2005-07-29 | Valley Forge Pharmaceuticals | Pirenzepine ophthalmic gel |
FR2834511B1 (fr) | 2002-01-07 | 2004-02-13 | Sanofi Synthelabo | Derives de 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, leur preparation et leur application en therapeutique |
CN1546490A (zh) | 2003-12-15 | 2004-11-17 | 常俊标 | 不对称双羟基托品类生物碱及其合成新方法和药物用途 |
CN1283639C (zh) | 2004-06-08 | 2006-11-08 | 吴建梅 | 治疗近视眼的哌仑西平有机酸盐及其滴眼剂 |
US20070254914A1 (en) * | 2006-05-01 | 2007-11-01 | Non-Profit Organization Chang Gung Memorial Hospital | Low-concentration atropine solution for preventing myopia progression and preparing method thereof |
CA2822758C (en) | 2010-12-22 | 2018-03-20 | Meiji Seika Pharma Co., Ltd. | Optically active diazabicyclooctane derivative and process for preparing the same |
-
2018
- 2018-11-02 KR KR1020207010292A patent/KR20200083976A/ko not_active Application Discontinuation
- 2018-11-02 TW TW107138927A patent/TWI826399B/zh active
- 2018-11-02 AU AU2018362010A patent/AU2018362010B2/en active Active
- 2018-11-02 WO PCT/IB2018/058631 patent/WO2019087146A1/en active Application Filing
- 2018-11-02 SG SG11202002692XA patent/SG11202002692XA/en unknown
- 2018-11-02 CA CA3076457A patent/CA3076457C/en active Active
- 2018-11-02 US US16/760,192 patent/US11306090B2/en active Active
- 2018-11-02 CA CA3205816A patent/CA3205816A1/en active Pending
- 2018-11-02 MX MX2020004580A patent/MX2020004580A/es unknown
- 2018-11-02 EP EP18800336.2A patent/EP3704117A1/en active Pending
- 2018-11-02 JP JP2020520577A patent/JP7065180B2/ja active Active
- 2018-11-02 BR BR112020007744-5A patent/BR112020007744A2/pt unknown
- 2018-11-02 CN CN201880068606.5A patent/CN111247147A/zh active Pending
- 2018-11-02 WO PCT/IB2018/058637 patent/WO2019087149A1/en active Application Filing
-
2020
- 2020-07-13 MX MX2022011310A patent/MX2022011310A/es unknown
-
2021
- 2021-07-16 AU AU2021205100A patent/AU2021205100B2/en active Active
-
2022
- 2022-03-21 US US17/699,606 patent/US11884666B2/en active Active
- 2022-04-25 JP JP2022071400A patent/JP2022101654A/ja active Pending
-
2023
- 2023-04-03 AU AU2023202036A patent/AU2023202036A1/en active Pending
- 2023-11-30 US US18/524,807 patent/US20240132497A1/en active Pending
-
2024
- 2024-01-18 JP JP2024006023A patent/JP2024041971A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2022101654A (ja) | 2022-07-06 |
WO2019087149A1 (en) | 2019-05-09 |
US20220267328A1 (en) | 2022-08-25 |
SG11202002692XA (en) | 2020-05-28 |
CA3076457A1 (en) | 2019-05-09 |
US11884666B2 (en) | 2024-01-30 |
US20210179616A1 (en) | 2021-06-17 |
TWI826399B (zh) | 2023-12-21 |
RU2020117733A (ru) | 2021-12-03 |
JP7065180B2 (ja) | 2022-05-11 |
WO2019087146A1 (en) | 2019-05-09 |
AU2021205100B2 (en) | 2023-01-05 |
US11306090B2 (en) | 2022-04-19 |
JP2020536922A (ja) | 2020-12-17 |
CA3076457C (en) | 2023-09-19 |
KR20200083976A (ko) | 2020-07-09 |
EP3704117A1 (en) | 2020-09-09 |
CA3205816A1 (en) | 2019-05-09 |
MX2022011310A (es) | 2022-10-07 |
AU2018362010B2 (en) | 2021-05-13 |
BR112020007744A2 (pt) | 2020-10-13 |
AU2018362010A1 (en) | 2020-04-09 |
CN111247147A (zh) | 2020-06-05 |
TW201922731A (zh) | 2019-06-16 |
AU2021205100A1 (en) | 2021-08-12 |
AU2023202036A1 (en) | 2023-05-04 |
US20240132497A1 (en) | 2024-04-25 |
JP2024041971A (ja) | 2024-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ737399A (en) | Ccr2 modulators | |
PH12015502621A1 (en) | Estrogen receptor modulator and uses thereof | |
PH12019502058A1 (en) | Farnesoid x receptor agonists and uses thereof | |
EA201791239A8 (ru) | ТЕТРАГИДРОПИРИДО[3,4-b]ИНДОЛОВЫЕ МОДУЛЯТОРЫ ЭСТРОГЕНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ | |
MX2018009752A (es) | 1,2,3,-triazoles sustituidos como moduladores de nmda selectivos de nr2b. | |
PH12014502095A1 (en) | Estrogen receptor modulators and uses thereof | |
MX2015016171A (es) | Moduladores del receptor de estrogeno de azetidina y usos de los mismos. | |
PH12018501731A1 (en) | Positive allosteric modulators of the muscarinic acetylcholine receptor m1 | |
PH12014501351B1 (en) | Fluorinated estrogen receptor modulators and uses thereof | |
MX2014012945A (es) | Derivados de pirazol aminopirimidina como moduladores de cinasa 2 de repeticion rica en leucina (lrrk2). | |
EA201591403A1 (ru) | Спиролактамные модуляторы рецептора nmda и их применение | |
MX2013002975A (es) | Moduladores de receptores de estrogenos y usos de los mismos. | |
MX2018000352A (es) | 4-azaindoles sustituidos y su uso como moduladores del receptor glun2b. | |
MX2021015500A (es) | Pirazolo-pirazinas sustituidas y su uso como moduladores del receptor glun2b. | |
CR20210615A (es) | Pirazolo piridinas heteroaromáticas sustituidas y su uso como moduladores del receptor glun2b | |
NZ736055A (en) | Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators | |
JOP20210328A1 (ar) | مركبات أميدات بيريدين-بيرازولو المستبدلة واستخدامها باعتبارها معدِّلات لمستقبل الغلوتومات "glun2b" | |
MX361349B (es) | Moduladores del receptor x del higado (lxr) para el tratamiento de enfermedades, trastornos y condiciones dérmicas. | |
WO2014066799A3 (en) | Modulators of resistant androgen receptor | |
MX2023000677A (es) | Compuestos moduladores de receptor de estrogeno. | |
MX2018002446A (es) | Compuestos heterociclicos fusionados como moduladores s1p. | |
MX2022011310A (es) | Azabiciclo y derivados de diazepina para tratar trastornos oculares. | |
CR20200346A (es) | Oligonucleótidos para modular la expresión de tmem106b | |
MX2016002931A (es) | Moduladores del receptor x hepatico (lxr). | |
BR112021014566A2 (pt) | Moduladores de gpr35 |